Article
Study seeks to define metastatic risk factors of select patients
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Unlocking Skin's Potential from the Inside Out with Glutathione
The Cutaneous Connection: Combatting Treatment Skepticism in Advanced Pediatric Atopic Dermatitis
Evolving Pediatric AD Care Through Individualized Topical Therapy and Patient-Centered Approaches
The Cutaneous Connection: Using the Color Wheel to Discuss Nutrition
FDA Clears Dermalogica's PRO Pen Microneedling System as a Class II Medical Device
Clinical Trials Support New Retinal Formulation Tolerability
The Aesthetic Edge: September 2025
Biofrontera Completes Enrollment and Active Treatment Phase in Phase 3 Ameluz PDT Trial for AK on the Body
Experts Urge a New Standard for Short-Term Corticosteroid Use in Atopic Dermatitis